Anti Progesterone Drugs Mifepristone Steroid Hormones Bodybuilding Light Yellow Powder

Anti Progesterone Drugs Mifepristone Steroid Hormones Bodybuilding Light Yellow Powder

bargain

add to cart

Description:

Mifepristone blocks a hormone required to sustain the pregnancy. Typically it is followed two days


later by another medicinal, misoprostol, to induce contractions, and the pregnancy is terminated.


Mifepristone is also know as RU486. The FDA has approved Mifepristone for use in the United


States. Mifepristone has been used extensively in France and several other countries. Over half a


million woman have had a medical abortion using Mifepristone.


Application:


Mifepristone plays a role on the receptor level of new antifertility drugs, no progesterone,


androgen, estrogen activity.It has an effect on softening and dilating uterine neck. It is a new anti -


progesterone, and anti-glucocorticoid activity, without progesterone, estrogen, androgen and


estrogen activity. And progesterone receptor affinity is 5 times stronger than progesterone. For


termination of early pregnancy, reinstating menstruation and terminating pregnancy, fetal death,


etc. in induction of labor.

Mifepristone action principle that by blocking the progesterone receptor and the production of


anti-pregnancy role, the effects and has been widely used clinically. Mifepristone and


prostaglandin drugs used, can be used to terminate an early pregnancy amenorrhea within 49d.


Usage of a total of 150mg of mifepristone Dayton clothing or in divided doses, the first paragraph


4d 3d or oral misoprostol 600ug, abortion drug application, greatly reducing the complications


caused by abortions, reducing the majority suffering women of childbearing age.


Lab Test Result:



Test Items


Standard


Results


Description


Light yellow crystalline powder


Conform


Melting Point


192ºC~196ºC


Conform


Specific Rotation


+124°~ +129°


+127.1°


Related substances


(Single):≤0.5%


0.31%


(Total):≤1.0%


0.59%


Loss On Drying


≤0.5%


0.1%


Assay


≥98.5%


99.5%


Sieve analysis


≤30¦Ìm


Conform


Conclusion


The specification conforms to CP 2010 standard


Skype&Whatsapp:86 13690838732

Email: ycsales12@ycphar.com